---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-002172"
form_type: "8-K"
ticker: "SNDX"
cik: "0001395937"
company_name: "Syndax Pharmaceuticals Inc"
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:35:41.123701+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Syndax adopts 2023 Inducement Plan, reserving 1.9M shares for new-hire equity grants

## Summary
- Board approved 2023 Inducement Plan on Feb 2, 2023, under Nasdaq Rule 5635(c)(4) for inducement grants.
- Plan reserves 1.9M shares of common stock for issuance to new employees as material inducement to employment.
- Plan is substantially similar to 2015 Omnibus Incentive Plan but prohibits incentive stock options.
- Grants require approval by a majority of Independent Directors or Independent Compensation Committee.

## SEC filing metadata
- accession: 0000950170-23-002172
- form_type: 8-K
- ticker: SNDX
- cik: 0001395937
- company_name: Syndax Pharmaceuticals Inc
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1395937/000095017023002172/0000950170-23-002172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1395937/000095017023002172/sndx-20230202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-002172
- JSON: https://secwatch.observer/filing/0000950170-23-002172.json
- Plain text: https://secwatch.observer/filing/0000950170-23-002172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.